Dr. Sepuri Krishna Mohan (Endocrinology) needs a second opinion on this medical case.
Dear my friends and fellow Colleagues, In patients at increased cardiovascular risk receiving metformin-based background therapy, specific GLP-1 RAs and SGLT-2 inhibitors have a favorable effect on certain cardiovascular outcomes. Annals of Internal Medicine. 30th June, 2020. Regards and thanks, Dr Sepuri Krishna Mohan.
See this content immediately after install